Related Experiment Video
Updated: Jun 3, 2026
05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Maternal insulin resistance and preeclampsia
John C Hauth1, Rebecca G Clifton, James M Roberts
1Department of Obstetrics and Gynecology, University of Alabama, Birmingham, School of Medicine, Birmingham, AL 35249-7333, USA. jchauth@uab.edu
American Journal of Obstetrics and Gynecology
|April 5, 2011
Summary
Mid-trimester insulin resistance, a marker of metabolic dysfunction, is linked to a higher risk of developing preeclampsia in nulliparous women. This finding highlights potential early detection and intervention strategies for this pregnancy complication.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Metabolic Health
Background:
- Preeclampsia is a serious pregnancy complication.
- Insulin resistance may play a role in preeclampsia development.
- Early identification of risk factors is crucial for maternal health.
Purpose of the Study:
- To investigate the association between mid-trimester insulin resistance and the subsequent development of preeclampsia.
- To determine if insulin resistance measured in early pregnancy predicts preeclampsia risk.
Main Methods:
- Secondary analysis of a cohort of 10,154 nulliparous women.
- Fasting plasma glucose and insulin levels measured between 22-26 weeks gestation in 1187 women.
- Insulin resistance assessed using homeostasis model assessment of insulin resistance (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI).
Main Results:
- Higher insulin resistance (HOMA-IR ≥75th percentile) was observed in obese, Hispanic, and African American women.
- Women who developed preeclampsia had significantly higher mid-trimester insulin resistance compared to normotensive women (40.5% vs 24.8%).
- Elevated HOMA-IR was associated with a nearly twofold increased odds of preeclampsia (adjusted OR, 1.9; 95% CI, 1.1-3.2).
Conclusions:
- Mid-trimester maternal insulin resistance is a significant predictor of subsequent preeclampsia.
- These findings suggest that insulin resistance is an important pathophysiological factor in preeclampsia.
- Early assessment of insulin resistance may aid in identifying women at high risk for preeclampsia.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...